Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
betametason 0,05 % + salicylsyra 3 %, för applicering i hårbottnen |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
zink + salicylsyra (halv styrka), pasta |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyra 3 % + borsyra i renat talk 5 %, pulver |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyra 5 % + zinkoxid 20 %, puder |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyra 60 % i vitt mjukt paraffin 40 %, salva |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyra 17 %, vätska |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyra 16,7 % + mjölksyra 16,7 %, preparat för pensling |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
mjölksyra 16,7 % vikt per vikt + salicylsyra 16,7 % vikt per vikt |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyragel |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyraplåster 20 %, 7,5 cm x 4,5 cm |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyraplåster 40 %, 7,5 cm x 4,5 cm |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
salicylsyra 3 % + borsyra 5 %, puder |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Salicylic acid 110 mg/g cutaneous gel |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Salicylic acid 60 mg/g cutaneous gel |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
False |
salicylsyra för lokalt bruk |
Inferred relationship |
Some |
|